Eton Pharmaceuticals Announces FDA Approval of Rezipres® (Ephedrine Hydrochloride Injection)
15. Juni 2021 10:37 ET
|
Eton Pharmaceuticals
DEER PARK, Ill., June 15, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON) today announced that the U.S. Food and Drug Administration (FDA) has approved Rezipres® (ephedrine...
Eton Pharmaceuticals Receives Complete Response Letter from U.S. FDA for Dehydrated Alcohol Injection
28. Mai 2021 08:05 ET
|
Eton Pharmaceuticals
DEER PARK, Ill., May 28, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), today announced that the company has received a Complete Response Letter (CRL) from the U.S. Food &...
Eton Pharmaceuticals Reports Record Revenue and Earnings
13. Mai 2021 16:05 ET
|
Eton Pharmaceuticals
First quarter 2021 revenue of $11.9 millionFirst quarter 2021 operating earnings of $5.4 million; EPS of $0.19Eton now has three commercial, revenue-generating products DEER PARK, Ill., May 13, 2021...
Eton Pharmaceuticals to Report First Quarter 2021 Financial Results on Thursday, May 13, 2021
04. Mai 2021 16:05 ET
|
Eton Pharmaceuticals
DEER PARK, Ill., May 04, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare...
Eton Pharmaceuticals Announces Appointment of Jenn Adams to its Board of Directors
17. März 2021 16:05 ET
|
Eton Pharmaceuticals
DEER PARK, Ill., March 17, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare...
Eton Pharmaceuticals Announces Fourth Quarter and Full Year 2020 Financial Results
16. März 2021 16:02 ET
|
Eton Pharmaceuticals
DEER PARK, Ill., March 16, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare...
Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2020 Financial Results on Tuesday, March 16, 2021
04. März 2021 16:05 ET
|
Eton Pharmaceuticals
DEER PARK, Ill., March 04, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for...
Eton Pharmaceuticals to Participate in 10th Annual SVB Leerink Global Healthcare Conference
16. Februar 2021 16:05 ET
|
Eton Pharmaceuticals
DEER PARK, Ill., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for...
Eton Pharmaceuticals Announces Sale of Neurology Portfolio
08. Februar 2021 08:00 ET
|
Eton Pharmaceuticals
Eton to receive up to $45 million plus royalties on product sales DEER PARK, Ill., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (Nasdaq: ETON), a specialty pharmaceutical company...
Eton Pharmaceuticals Announces Acquisition of Canadian Rights for ALKINDI® SPRINKLE
14. Januar 2021 08:00 ET
|
Eton Pharmaceuticals
DEER PARK, Ill., Jan. 14, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for...